In the News | Friends of Cancer Research

You are here

In the News

January 29, 2019
Randomized controlled clinical trials are a great way to test the safety and effectiveness of a new drug. But when the trial is over and the drug approved, it’s used by patients and health care... Read more
January 29, 2019
Real-world evidence (RWE) or real-world data (RWD) relates to the collection of information about a drug’s safety and efficacy outside the structure of a clinical trial. Speaking yesterday at the... Read more
January 29, 2019
SWOG's Lung Cancer Master Protocol (Lung-MAP) precision medicine trial is implementing new protocols and expanding to include all advanced stage non-small cell lung cancer patients, moving beyond its... Read more
January 29, 2019
The Lung Cancer Master Protocol, or Lung-MAP, will expand to include all patients diagnosed with non-small cell lung cancer.   Lung-MAP — the first large-scale precision medicine lung cancer trial... Read more
January 29, 2019
Washington, DC – The Lung Cancer Master Protocol (Lung-MAP), the first precision medicine trial in lung cancer supported by the National Cancer Institute (NCI), part of the National Institutes of... Read more
January 21, 2019
In an effort to ensure that study participants are more reflective of real-world populations, the National Cancer Institute (NCI) has revised its clinical trial protocols to expand access for... Read more
January 17, 2019
Friends Welcomes Margaret Anderson, Edward J. Benz Jr, and Elizabeth Thompson January 17, 2019 – Washington, DC – Friends of Cancer Research (Friends) is pleased to announce the additions of Margaret... Read more
January 16, 2019
Patients with cancer who also have other health issues are less likely to participate in a clinical trial, potentially leaving gaps in understanding how drugs may affect individuals with certain... Read more
January 16, 2019
Presence of comorbidities is associated with fewer patient-physician discussions regarding clinical trials, with fewer offers made and less patient participation, according to a report published in... Read more
January 16, 2019
Unnecessarily restrictive criteria for clinical trial participation excluding those with comorbidities excludes many "real-world" cancer patients and prevents them from potentially benefiting from... Read more

Pages